Final Analysis on Long-term Survival and Late Toxicities for a Randomized Phase II Study of Cisplatin/5-FU Concurrent Chemoradiotherapy for Esophageal Cancer (KROSG-0101, JROSG-021)

Y. Nishimura; M. Mitsumori; M. Hiraoka; R. Koike; K. Nakamatsu; M. Kawamura; N. Araki; T. Fujii; T. Takahashi; N. Mitsuhashi

doi:10.1016/j.ijrobp.2010.07.708

Final Analysis on Long-term Survival and Late Toxicities for a Randomized Phase II Study of Cisplatin/5-FU Concurrent Chemoradiotherapy for Esophageal Cancer (KROSG-0101, JROSG-021)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2010.07.708 ◽

2010 ◽

Vol 78 (3) ◽

pp. S297-S298

Author(s):

Y. Nishimura ◽

M. Mitsumori ◽

M. Hiraoka ◽

R. Koike ◽

K. Nakamatsu ◽

...

Keyword(s):

Esophageal Cancer ◽

Phase Ii ◽

Concurrent Chemoradiotherapy ◽

Phase Ii Study ◽

Final Analysis ◽

Term Survival ◽

Long Term Survival ◽

Randomized Phase Ii

Download Full-text

IMCT-08ReACT: LONG-TERM SURVIVAL FROM A RANDOMIZED PHASE II STUDY OF RINDOPEPIMUT (CDX-110) PLUS BEVACIZUMAB IN RELAPSED GLIOBLASTOMA

Neuro-Oncology ◽

10.1093/neuonc/nov218.08 ◽

2015 ◽

Vol 17 (suppl 5) ◽

pp. v109.1-v109 ◽

Cited By ~ 17

Author(s):

David A. Reardon ◽

Annick Desjardins ◽

James Schuster ◽

David D. Tran ◽

Karen L. Fink ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Term Survival ◽

Long Term Survival ◽

Randomized Phase Ii

Download Full-text

Radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM): Long-term survival results of a randomized phase II study of the EORTC-NCRI CCSG-ALM Intergroup 40004 (CLOCC).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.3501 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 3501-3501 ◽

Cited By ~ 32

Author(s):

Theo Ruers ◽

Cornelis J. A. Punt ◽

Frits van Coevorden ◽

Jean-Pierre Pierie ◽

Inne Borel Rinkes ◽

...

Keyword(s):

Radiofrequency Ablation ◽

Liver Metastases ◽

Phase Ii ◽

Colorectal Liver Metastases ◽

Phase Ii Study ◽

Term Survival ◽

Long Term Survival ◽

Randomized Phase Ii ◽

Unresectable Colorectal Liver Metastases

Download Full-text

Long-term Follow-up of a Randomized Phase II Study of Cisplatin/5-FU Concurrent Chemoradiotherapy for Esophageal Cancer (KROSG0101/JROSG021)

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hys112 ◽

2012 ◽

Vol 42 (9) ◽

pp. 807-812 ◽

Cited By ~ 23

Author(s):

Y. Nishimura ◽

M. Hiraoka ◽

R. Koike ◽

K. Nakamatsu ◽

S. Itasaka ◽

...

Keyword(s):

Esophageal Cancer ◽

Phase Ii ◽

Concurrent Chemoradiotherapy ◽

Phase Ii Study ◽

Randomized Phase Ii ◽

Long Term Follow Up

Download Full-text

Long-Term Survival in Metastatic Melanoma Patients Treated with Sequential Biochemotherapy: Report of a Phase II Study

Cancer Investigation ◽

10.1080/07357900600817758 ◽

2006 ◽

Vol 24 (5) ◽

pp. 474-478 ◽

Cited By ~ 6

Author(s):

B. Neri ◽

L. Vannozzi ◽

C. Fulignati ◽

P. Pantaleo ◽

D. Pantalone ◽

...

Keyword(s):

Metastatic Melanoma ◽

Phase Ii ◽

Phase Ii Study ◽

Term Survival ◽

Long Term Survival ◽

Melanoma Patients

Download Full-text

Abstract P1-14-09: Long term survival of locally advanced breast cancers (LABC) treated with neoadjuvant treatment, results of a multicenter randomised phase II study (Remagus 02 trial)

10.1158/1538-7445.sabcs15-p1-14-09 ◽

2016 ◽

Author(s):

S Giacchetti ◽

A-S Hamy-Petit ◽

S Delaloge ◽

E Brain ◽

F Berger ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Neoadjuvant Treatment ◽

Advanced Breast ◽

Breast Cancers ◽

Treatment Results ◽

Term Survival ◽

Long Term Survival

Download Full-text

Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survival

Bone Marrow Transplantation ◽

10.1038/sj.bmt.1702793 ◽

2001 ◽

Vol 27 (4) ◽

pp. 397-404 ◽

Cited By ~ 11

Author(s):

K van Besien ◽

A Rodriguez ◽

S Tomany ◽

A Younes ◽

M Donato ◽

...

Keyword(s):

Growth Factor ◽

Phase Ii ◽

Chemotherapy Regimen ◽

Phase Ii Study ◽

Response Rates ◽

High Dose ◽

Term Survival ◽

Long Term Survival ◽

Limited Impact

Download Full-text

Long-term survival in SCLC after treatment with paclitaxel, carboplatin and etoposide—A phase II study

Lung Cancer ◽

10.1016/s0169-5002(02)00383-5 ◽

2003 ◽

Vol 39 (1) ◽

pp. 63-69 ◽

Cited By ~ 6

Author(s):

Martin Reck ◽

Urzula Jagos ◽

Franziska Grunwald ◽

Eckhard Kaukel ◽

Gabriele Koschel ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Term Survival ◽

Long Term Survival

Download Full-text

Randomized phase II trial of CODE or AP after chemoradiotherapy for LD-SCLC: Long-term survival and toxicity analysis

Annals of Oncology ◽

10.1093/annonc/mdz264.005 ◽

2019 ◽

Vol 30 ◽

pp. v712

Author(s):

Sekine ◽

H. Harada ◽

N. Yamamoto ◽

M. Wakabayashi ◽

H. Murakami ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Term Survival ◽

Long Term Survival ◽

Randomized Phase Ii ◽

Toxicity Analysis

Download Full-text

Randomized Phase II Study of Preoperative Concurrent chemoradiotherapy with or without Induction Chemotherapy with S-1 and Oxaliplatin in Patients with Resectable Esophageal Cancer

Annals of Oncology ◽

10.1016/s0923-7534(20)32046-9 ◽

2012 ◽

Vol 23 ◽

pp. xi45-xi46

Author(s):

D.H. Yoon ◽

G. Jang ◽

J.H. Kim ◽

Y.-H. Kim ◽

S. Son ◽

...

Keyword(s):

Esophageal Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Concurrent Chemoradiotherapy ◽

Phase Ii Study ◽

Randomized Phase Ii ◽

Resectable Esophageal ◽

Resectable Esophageal Cancer

Download Full-text

O-018 Radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM): Long-term survival results of a randomised phase II study of the EORTC-NCRI CCSG-ALM Intergroup 40004 (CLOCC)

Annals of Oncology ◽

10.1093/annonc/mdv235.17 ◽

2015 ◽

Vol 26 ◽

pp. iv114 ◽

Cited By ~ 11

Author(s):

T. Ruers ◽

C.J.A. Punt ◽

F. van Coevorden ◽

J.-P. Pierie ◽

I. Borel Rinkes ◽

...

Keyword(s):

Radiofrequency Ablation ◽

Liver Metastases ◽

Phase Ii ◽

Colorectal Liver Metastases ◽

Phase Ii Study ◽

Term Survival ◽

Long Term Survival ◽

Unresectable Colorectal Liver Metastases

Download Full-text